Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients ; volume:4 ; number:1 ; day:10 ; month:11 ; year:2011 ; pages:1-9 ; date:12.2011
Journal of ovarian research ; 4, Heft 1 (10.11.2011), 1-9, 12.2011
- Urheber
-
Felisiak-Golabek, Anna
Rembiszewska, Alina
Rzepecka, Iwona K.
Szafron, Lukasz
Madry, Radoslaw
Murawska, Magdalena
Napiorkowski, Tomasz
Sobiczewski, Piotr
Osuch, Beata
Kupryjanczyk, Jolanta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1757-2215-4-20
- URN
-
urn:nbn:de:101:1-2021080921190711050956
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Felisiak-Golabek, Anna
- Rembiszewska, Alina
- Rzepecka, Iwona K.
- Szafron, Lukasz
- Madry, Radoslaw
- Murawska, Magdalena
- Napiorkowski, Tomasz
- Sobiczewski, Piotr
- Osuch, Beata
- Kupryjanczyk, Jolanta
- SpringerLink (Online service)
Ähnliche Objekte (12)
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
Cancer nuclear envelope rupture and repair in taxane resistance
Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)
Taxane-Induced Upper Gastrointestinal Bleeding
A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis
Platinum resistance in breast and ovarian cancer cell lines
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
Cancer nuclear envelope rupture and repair in taxane resistance
Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)
Taxane-Induced Upper Gastrointestinal Bleeding
A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis
Platinum resistance in breast and ovarian cancer cell lines
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study
Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
Cancer nuclear envelope rupture and repair in taxane resistance
Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition
Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer
Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial)
Taxane-Induced Upper Gastrointestinal Bleeding
A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)
Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis